Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Iatrogenic neonatal hypoglycaemia |
French
|
Hypoglycémie néonatale iatrogène |
| Level | Code | Title | |
|---|---|---|---|
| 1 | XVI | Certain conditions originating in the perinatal period | |
| 2 | P70-P74 | Transitory endocrine and metabolic disorders specific to fetus and newborn | |
| 3 | P70 | Transitory disorders of carbohydrate metabolism specific to fetus and newborn | |
| 4 | P70.3 | Iatrogenic neonatal hypoglycaemia |
| Active Ingredient | Description | |
|---|---|---|
| Diazoxide |
Diazoxide is a peripheral vasodilator and has qualitatively the same effect on blood vessels as benzothiazine compounds, but the effect is more rapid and profound. Unlike benzothiazines, diazoxide is non-diuretic and causes retention of sodium and water. It causes a prompt increase in blood glucose by a direct inhibitory action on the secretion of insulin by the beta cells in the Islets of Langerhans. |
|
| Glucose |
Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body. |
